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Abstract
Background: Fractures of the proximal humerus are common injuries and account for 4–5
percent of all fractures, second only to hip and wrist fractures. The incidence is positively
correlated with age and osteoporosis, and is likely to increase. Displaced four-part fractures are
among the most severe injuries, accounting for 2–10 percent of proximal humeral fractures. The
optimal intervention is disputed. Two previous randomised trials were very small and involved a
noticeable risk of bias, and systematic reviews consequently conclude that there is inadequate basis
for evidence-based treatment decisions. We aim to compare the effect of osteosynthesis with
angle-stable plate with non-surgical management, and the effect of primary hemiarthroplasty with
both osteosynthesis and non-surgical management.
Methods/Design: We will conduct a randomised, multi-centre, clinical trial including patients
from ten national shoulder units within a two-year period. We plan to include 162 patients. A
central randomisation unit will allocate patients. All patients will receive a standardised three-
month rehabilitation program of supervised physiotherapy regardless of treatment allocation.
Patients will be followed at least one year. The primary outcomes will be the overall score on the
Constant Disability Scale, and its pain subscale, measured at 12 months. A blinded physiotherapist
will carry out the assessments. Other secondary outcomes are Oxford Shoulder Score, and general
health status (Short Form-36).
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Background
Fractures of the proximal humerus are common injuries
and account for 4–5 percent of all fractures[1,2]. The inci-
dence is expected to increase due to its association with
advanced age and osteoporosis [3-5]. Displaced four-part
fractures are among the most severe injuries accounting
for 2–10 per cent of all proximal humeral fractures [6-8]
and for about one out of four operated proximal humeral
fractures[9].
The optimal treatment for displaced four-part fractures is
disputed. Several surgical techniques have been suggested
including transcutaneus reduction, external fixation,
hemiarthroplasty or open reduction and internal fixation
with Kirschner wiring, tension-band wiring, transosseous
suturing, plate fixation, intramedullary rod fixation, screw
fixation, or, most recently, angle-stable plates. Numerous
clinical series have been published, but most techniques
have shown unsatisfactory results except in 'valgus
impacted' fracture patterns (Fig. 1) or in selected younger
populations [10-14].
Two previous very small randomised clinical trials com-
pared treatments for displaced four-part fractures. Stable-
forth[8] compared arthroplasty with non-surgical
management on 32 patients. The result tended to favour
surgery. Hoellen[15] compared arthroplasty with osteo-
synthesis on 30 patients, but found no statistically signif-
icant difference in outcome. Both trials had low power,
and did not report clearly adequate concealment of
patient allocation or blinding procedures. The trials were
analysed and summarised in a Cochrane review[16] that
emphasised that the limited evidence available does not
even confirm that surgery is preferable to conservative
treatment in displaced fractures. Other systematic reviews
have concluded that published data are inadequate for
evidence-based decision making[6,17].
Aims
Our primary aim is to compare the effect of osteosynthesis
with angle-stable plate with non-surgical management for
displaced four-part fractures in elderly. We also aim to
compare the effect of primary hemiarthroplasty with both
osteosynthesis and with non-surgical management.
Our secondary aim is to study prognostic differences
between two pathoanatomical patterns of displaced four-
part fractures: 'valgus impacted' four-part fractures and
'classical' four-part fractures (Fig. 1) [18].
Methods/Design
A randomised, multi-centre, national, clinical trial.
Inclusion criteria
We will include patients diagnosed with a displaced four-
part fracture within a two-year recruitment period from
ten Danish hospitals providing advanced shoulder serv-
ice. Eligibility criteria will be: age ≥ 60 years, patients men-
tally alert and physically fit (ASA-group 1–3) for surgery
and rehabilitation.
The diagnoses of four-part fractures will be based on plain
radiographs (at least two perpendicular views) and any
available supplemental imaging material (CT or 3D CT).
At least two consenting experienced shoulder surgeons
should classify the fracture as a displaced four-part frac-
ture. The timing of the classification, and the subsequent
recruitment procedure, will be such that an operation can
be conducted within two weeks of injury.
Exclusion criteria
We will exclude patients with fracture-dislocations, head-
splitting fractures, previous shoulder surgery, chronic
shoulder pain, abuse problems, and patients unable to
understand instructions in Danish and follow the rehabil-
itation protocol at their local hospital.
Randomisation and concealment of allocation
After obtaining informed consent patients will be
included in the trial and randomly allocated to three
groups of equal size:
￿ Non-surgical management (physiotherapy and self-
training).
￿ Osteosynthesis with angle-stable plate followed by
physiotherapy and self-training. If osteosynthesis dur-
ing the operation is regarded surgically impossible by
Two patterns of displaced four-part fractures Figure 1
Two patterns of displaced four-part fractures. 
Reprinted from Murray and Zuckerman [18].Trials 2009, 10:51 http://www.trialsjournal.com/content/10/1/51
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the operating surgeon the operation will be converted
to primary modular hemiarthroplasty.
￿ Primary modular hemiarthroplasty followed by
physiotherapy and self-training.
The randomisation sequence will be computer generated.
A remotely placed randomisation unit, otherwise not
involved in the study, will irreversibly include patients
into the trial before allocating them to treatment groups,
communicating the result to the recruiting surgeon
through telephone.
After randomisation the patients and surgeon involved
will be informed about the patient's allocation to either
non-surgical management or to surgical management, but
they will not be informed about the type of surgery. The
surgical procedure (osteosynthesis or hemiarthroplasty)
will be revealed to the operating team just before the oper-
ation.
Interventions
Surgery will be performed within 14 days of injury by a
trained shoulder surgeon familiar with both surgical inter-
ventions. Operative techniques follow standardised
instructions.
All patients will receive a standardised rehabilitation pro-
gram of supervised physiotherapy and instructed self-
training regardless of treatment allocation. The local phys-
iotherapists will be involved in the assessment of the out-
come after 12 months and will record compliance with
the rehabilitation program.
Evaluation
All patients will be followed actively for one year post
injury. They will be seen by the responsible shoulder-sur-
geon in the out-patient clinic at two weeks, six months
and 12 months. All patients will be radiographed (at least
two plain perpendicular radiographs) prior to each visit.
Clinical outcome assessment will be performed after six
and 12 months by a blinded central physiotherapist not
involved in the rehabilitation of the patient. In addition,
the local physiotherapists will assess outcome after 12
months. The evaluation procedure will follow a standard-
ised protocol.
Patients will be followed up after three years. No clinical
assessment will be carried out, but data on complications
that may have developed after the 12 months evaluation
is extracted from the clinical databases at each hospital
(discharge letters, discharge diagnosis, and if needed jour-
nal notes).
Outcome measures
Clinical outcome is evaluated using an observer adminis-
tered shoulder-specific score (Constant Disability
Scale)[19,20], a patient administered shoulder-specific
questionnaire (Oxford Shoulder Score)[21], and a patient
administered general health status questionnaire(Short
Form-36)[22,23].
The primary outcomes are
￿ Constant Disability Scale – total score (0–100
points) at 12 months
￿ Constant Disability Scale – pain subscale score (0–
15 points) at 12 months
Secondary outcomes are
￿ Shoulder function. Oxford Shoulder Score – total
score (12–60 points)
￿ General health. Short Form-36 questionnaire – total
score (0–100 points)
Patient drop-out and protocol violations
Patients who drop-out of the trial will be recorded, and
the reason for drop-out will be noted. Patients that do not
comply with self-training and physiotherapy will be
recorded. Patients that cross-over from one treatment
group to another (non-surgical management to secondary
hemiarthroplasty or osteosynthesis to primary hemiar-
throplasty) will be recorded.
Side-effects reporting
We will record any case of deep infection, nerve injury,
implant malposition, heterotopic ossification, avascular
necrosis, malunion, nonunion, instability, dislocation,
implant removal and revision surgery. We also record any
case of pulmonary embolism, other medical complica-
tions, and death by any cause during the follow-up
period.
Statistical analysis plan
Sample size and power calculation (ANOVA)
To have an 80% chance of detecting as significant (at the
5% level) a ten point difference or more in mean total
Constant score between the three groups, with an
assumed standard deviation of 15 points and a loss to fol-
low up of 10 patients in each group, a total of 162 patients
is required.
Data-analysis
No interim data-analysis will be carried out. The data-
analysis will be conducted by a biostatician at the end of
the follow-up period.Trials 2009, 10:51 http://www.trialsjournal.com/content/10/1/51
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Patients randomised to the non-surgical management
group but who cross-over and undergo secondary surgery
will primarily be analysed as they were randomised. Sim-
ilarly, patients randomised to osteosynthesis but due to
surgical technical difficulties are treated with primary
hemiarthroplasty, will be analysed as randomised.
Patients that drop-out after the six months evaluation will
be included in the analysis based on six months data ('last
observation carried forward'). Drop-out of patients before
the six months evaluation cannot be included in the anal-
ysis.
Descriptive statistics (mean and standard deviations, as
well as median and 10 and 90 percentiles for continuous
variables, and frequency and 95 percent confidence inter-
val for binary variables) will be calculated for each of the
three groups, and their relevant subgroups, at both time
points. Relevant subgroups include:
￿ Valgus-impacted versus classical four-part fractures
￿ Cross-overs from non-surgical treatment to second-
ary hemiarthroplasty versus non cross-overs in non-
surgical treatment group
￿ Cross-overs from osteosynthesis to primary hemiar-
throplasty versus non cross-overs in osteosynthesis
group.
Continuous and binary baseline characteristics will be
tabulated according to the three treatment groups. No sta-
tistical testing will be performed, but relevant imbalances
will be noted and reported. Baseline characteristics
include: age, ASA Score, patient's treatment preference,
surgeon's treatment preference and fracture pattern (val-
gus-impacted or classical four-part).
The primary analyses of effect will be two analyses of var-
iance (ANOVA) based on the overall Constant scores, and
the Constant pain subscale score, measured at 12 months.
We will use the last observation carried forward approach,
excluding patients only because of missing data, and ana-
lyse all patients according to their randomisation (inten-
tion-to-treat analysis).
If one or both of the ANOVA analyses are statistically sig-
nificant, we will subsequently perform a pair-wise testing
based on t-tests:
￿ Osteosynthesis versus non-surgical management.
￿ Hemiarthroplasty versus non-surgical management.
￿ Osteosynthesis versus hemiarthroplasty.
Thus, our protection against the risk of type 1 errors con-
sists on a clear definition of the two primary outcomes
and a single analysis ANOVA approach.
We will also conduct the following secondary analyses:
￿ The above analysis will be conducted for the follow-
ing two subgroups: valgus-impacted and classical frac-
tures respectively.
￿ In the osteosynthesis group we will conduct a sub-
group analysis comparing patients with intraoperative
change to hemiarthroplasty with those without.
￿ We will repeat the primary analysis as a mixed model
for repeated measurements (including data from six
months and the predefined covariates: age, ASA-Score,
and treatment preference at baseline).
￿ The number of patients with Constant score ≥ 70 at
month 12 for each group (and subgroup) will be com-
pared with Chi-square tests.
The same analyses (except the third) will be performed for
the other outcomes (Oxford Shoulder Score, Short Form-
36).
Finally, we will perform a per protocol effect analysis in
which only patients that were compliant with physiother-
apy and training (attending > 75% physiotherapy sessions
judged by physiotherapist) will be included.
The same analyses will be performed for the other out-
comes (Oxford Shoulder Score, Short Form-36).
A three year follow-up analysis will be reported in a sepa-
rate publication. The analyses will compare number of
patients in each group that died, received shoulder sur-
gery, etc.
Blinding
The trial will involve several levels of blinding:
￿ Patients, and all persons involved with the trial,
except the operation team, will be blinded to which
operation was performed.
￿ A central physiotherapist blinded to patients' treat-
ment will perform the clinical evaluation at 6 and
twelve months. During evaluation patients will be
wearing a shirt covering the shoulder and will have
been asked not to disclose their treatment status to the
physiotherapist, and the physiotherapists will be
asked to avoid from actively exploring patients' treat-
ment status. The blinding will be tested by asking theTrials 2009, 10:51 http://www.trialsjournal.com/content/10/1/51
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central physiotherapist to guess the patient's treatment
allocation.
￿ By the end of the study, but prior to the data analysis,
sub-classification in 'classical' and 'valgus-impacted'
fracture patterns will be made by four experienced
shoulder surgeons blinded to the patients' identity
based on the baseline radiographs. Disagreement will
be resolved by discussion.
￿ All three persons involved in the statistical analysis
(statistician, SB, AH) will be blinded with respect to
the treatment allocation, patient identity and surgeon
identity when conducting the primary analysis. When
conducting the additional statistical analysis the three
persons will be blinded only to the identity of patients
and surgeons.
Ethical issues
Each patient who wants to be part of the trial will be
informed orally and in writing. Those that decide to join
the trial will be asked to sign an informed consent form.
The study protocol, including the informed consent form
and patient information sheets have been approved by
The Committee on Medical Research Ethics, The Capital
Region of Denmark: Jr. H-C-2008-065. The processing of
personal data has been be approved by the Danish Data
Protection Agency.
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